The Helicobacter pylori cag pathogenicity island as a determinant of gastric cancer risk

References

• Hooi JKY, Lai WY, Ng WK, Suen MMY, Underwood FE, Tanyingoh D, Malfertheiner P, Graham DY, Wong VWS, Wu JCY. et al. Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis. Gastroenterology. 2017;153(2):420–22. doi:10.1053/j.gastro.2017.04.022.
   PubMed Web of Science ®Google Scholar
• Cover TL, Blaser MJ. Helicobacter pylori in health and disease. Gastroenterology. 2009;136(6):1863–73. doi:10.1053/j.gastro.2009.01.073.
   PubMed Web of Science ®Google Scholar
• Malfertheiner P, Camargo MC, El-Omar E, Liou JM, Peek R, Schulz C, Smith SI, Suerbaum S. Helicobacter pylori infection. Nat Rev Dis Primers. 2023;9(1):19. doi:10.1038/s41572-023-00431-8.
   PubMed Web of Science ®Google Scholar
• Suerbaum S, Josenhans C. Helicobacter pylori evolution and phenotypic diversification in a changing host. Nat Rev Microbiol. 2007;5(6):441–52. doi:10.1038/nrmicro1658.
   PubMed Web of Science ®Google Scholar
• Cover TL. Helicobacter pylori diversity and gastric cancer risk. MBio. 2016;7(1):e01869–15. doi:10.1128/mBio.01869-15.
   PubMed Web of Science ®Google Scholar
• Thorell K, Munoz-Ramirez ZY, Wang D, Sandoval-Motta S, Boscolo Agostini R, Ghirotto S, Torres RC, Hp GPRN, Falush D, Camargo MC. et al. The Helicobacter pylori genome project: insights into H. pylori population structure from analysis of a worldwide collection of complete genomes. Nat Commun. 2023;14(1):8184. doi:10.1038/s41467-023-43562-y.
   PubMed Web of Science ®Google Scholar
• Censini S, Lange C, Xiang Z, Crabtree JE, Ghiara P, Borodovsky M, Rappuoli R, Covacci A. cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci USA. 1996;93(25):14648–14653. doi:10.1073/pnas.93.25.14648.
   PubMed Web of Science ®Google Scholar
• Akopyants NS, Clifton SW, Kersulyte D, Crabtree JE, Youree BE, Reece CA, Bukanov NO, Drazek ES, Roe BA, Berg DE. Analyses of the cag pathogenicity island of Helicobacter pylori. Mol Microbiol. 1998;28(1):37–53. doi:10.1046/j.1365-2958.1998.00770.x.
   PubMed Web of Science ®Google Scholar
• Olbermann P, Josenhans C, Moodley Y, Uhr M, Stamer C, Vauterin M, Suerbaum S, Achtman M, Linz B. A global overview of the genetic and functional diversity in the Helicobacter pylori cag pathogenicity island. PloS Genet. 2010;6(8):e1001069. doi:10.1371/journal.pgen.1001069.
   PubMed Web of Science ®Google Scholar
• Chung JM, Sheedlo MJ, Campbell AM, Sawhney N, Frick-Cheng AE, Lacy DB, Cover TL, Ohi MD. Structure of the Helicobacter pylori Cag type IV secretion system. eLife. 2019;8:e47644. doi:10.7554/eLife.47644.
   PubMed Web of Science ®Google Scholar
• Sheedlo MJ, Chung JM, Sawhney N, Durie CL, Cover TL, Ohi MD, Lacy DB. Cryo-EM reveals species-specific components within the Helicobacter pylori Cag type IV secretion system core complex. Elife. 2020;9:e59495. doi:10.7554/eLife.59495.
   PubMed Web of Science ®Google Scholar
• Tummuru MK, Cover TL, Blaser MJ. Cloning and expression of a high-molecular-mass major antigen of Helicobacter pylori: evidence of linkage to cytotoxin production. Infect Immun. 1993;61(5):1799–809. doi:10.1128/iai.61.5.1799-1809.1993.
   PubMed Web of Science ®Google Scholar
• Covacci A, Censini S, Bugnoli M, Petracca R, Burroni D, Macchia G, Massone A, Papini E, Xiang Z, Figura N. et al. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci USA. 1993;90(12):5791–5795. doi:10.1073/pnas.90.12.5791.
   PubMed Web of Science ®Google Scholar
• Segal ED, Cha J, Lo J, Falkow S, Tompkins LS. Altered states: involvement of phosphorylated CagA in the induction of host cellular growth changes by Helicobacter pylori. Proc Natl Acad Sci USA. 1999;96(25):14559–14564. doi:10.1073/pnas.96.25.14559.
   PubMed Web of Science ®Google Scholar
• Stein M, Rappuoli R, Covacci A. Tyrosine phosphorylation of the Helicobacter pylori CagA antigen after cag-driven host cell translocation. Proc Natl Acad Sci USA. 2000;97(3):1263–1268. doi:10.1073/pnas.97.3.1263.
   PubMed Web of Science ®Google Scholar
• Odenbreit S, Puls J, Sedlmaier B, Gerland E, Fischer W, Haas R. Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science. 2000;287(5457):1497–1500. doi:10.1126/science.287.5457.1497.
   PubMed Web of Science ®Google Scholar
• Asahi M, Azuma T, Ito S, Ito Y, Suto H, Nagai Y, Tsubokawa M, Tohyama Y, Maeda S, Omata M. et al. Helicobacter pylori CagA protein can be tyrosine phosphorylated in gastric epithelial cells. J Exp Med. 2000;191(4):593–602. doi:10.1084/jem.191.4.593.
   PubMed Web of Science ®Google Scholar
• Backert S, Ziska E, Brinkmann V, Zimny-Arndt U, Fauconnier A, Jungblut PR, Naumann M, Meyer TF. Translocation of the Helicobacter pylori CagA protein in gastric epithelial cells by a type IV secretion apparatus. Cell Microbiol. 2000;2(2):155–64. doi:10.1046/j.1462-5822.2000.00043.x.
   PubMed Web of Science ®Google Scholar
• Fischer W, Puls J, Buhrdorf R, Gebert B, Odenbreit S, Haas R. Systematic mutagenesis of the Helicobacter pylori cag pathogenicity island: essential genes for CagA translocation in host cells and induction of interleukin-8. Mol Microbiol. 2001;42(5):1337–48. doi:10.1046/j.1365-2958.2001.02714.x.
   PubMed Web of Science ®Google Scholar
• Cover TL, Lacy DB, Ohi MD. The Helicobacter pylori Cag Type IV Secretion System. Trends Microbiol. 2020;28(8):682–695. doi:10.1016/j.tim.2020.02.004.
   PubMed Web of Science ®Google Scholar
• Cover TL, Dooley CP, Blaser MJ. Characterization of and human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity. Infect Immun. 1990;58(3):603–610. doi:10.1128/iai.58.3.603-610.1990.
   PubMed Web of Science ®Google Scholar
• Crabtree JE, Taylor JD, Wyatt JI, Heatley RV, Shallcross TM, Tompkins DS, Rathbone BJ. Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology. Lancet. 1991;338(8763):332–335. doi:10.1016/0140-6736(91)90477-7.
   PubMed Web of Science ®Google Scholar
• Cover TL, Glupczynski Y, Lage AP, Burette A, Tummuru MK, Perez-Perez GI, Blaser MJ. Serologic detection of infection with cagA+ Helicobacter pylori strains. J Clin Microbiol. 1995;33(6):1496–500. doi:10.1128/jcm.33.6.1496-1500.1995.
   PubMed Web of Science ®Google Scholar
• Nomura AM, Perez-Perez GI, Lee J, Stemmermann G, Blaser MJ. Relation between Helicobacter pylori cagA status and risk of peptic ulcer disease. Am J Epidemiol. 2002;155(11):1054–1059. doi:10.1093/aje/155.11.1054.
   PubMed Web of Science ®Google Scholar
• Crabtree JE, Wyatt JI, Sobala GM, Miller G, Tompkins DS, Primrose JN, Morgan AG. Systemic and mucosal humoral responses to Helicobacter pylori in gastric cancer. Gut. 1993;34(10):1339–43. doi:10.1136/gut.34.10.1339.
   PubMed Web of Science ®Google Scholar
• Blaser MJ, Perez-Perez GI, Kleanthous H, Cover TL, Peek RM, Chyou PH, Stemmermann GN, Nomura A. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res. 1995;55:2111–2115.
   PubMed Web of Science ®Google Scholar
• Kuipers EJ, Perez-Perez GI, Meuwissen SG, Blaser MJ. Helicobacter pylori and atrophic gastritis: importance of the cagA status. J Natl Cancer Inst. 1995;87(23):1777–80. doi:10.1093/jnci/87.23.1777.
   PubMedGoogle Scholar
• Parsonnet J, Friedman GD, Orentreich N, Vogelman H. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut. 1997;40(3):297–301. doi:10.1136/gut.40.3.297.
   PubMed Web of Science ®Google Scholar
• Huang JQ, Sridhar S, Chen Y, Hunt RH. Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology. 1998;114(6):1169–79. doi:10.1016/S0016-5085(98)70422-6.
   PubMed Web of Science ®Google Scholar
• Ekstrom AM, Held M, Hansson LE, Engstrand L, Nyren O. Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection. Gastroenterology. 2001;121(4):784–91. doi:10.1053/gast.2001.27999.
   PubMed Web of Science ®Google Scholar
• Nomura AM, Lee J, Stemmermann GN, Nomura RY, Perez-Perez GI, Blaser MJ. Helicobacter pylori CagA seropositivity and gastric carcinoma risk in a Japanese American population. J Infect Dis. 2002;186(8):1138–44. doi:10.1086/343808.
   PubMed Web of Science ®Google Scholar
• Huang JQ, Zheng GF, Sumanac K, Irvine EJ, Hunt RH. Meta-analysis of the relationship between cagA seropositivity and gastric cancer. Gastroenterology. 2003;125(6):1636–44. doi:10.1053/j.gastro.2003.08.033.
   PubMed Web of Science ®Google Scholar
• Palli D, Masala G, Del Giudice G, Plebani M, Basso D, Berti D, Numans ME, Ceroti M, Peeters PH, de Mesquita HB B. et al. CagA+ Helicobacter pylori infection and gastric cancer risk in the EPIC-EURGAST study. Int J Cancer. 2007;120(4):859–67. doi:10.1002/ijc.22435.
   PubMed Web of Science ®Google Scholar
• Shiota S, Matsunari O, Watada M, Yamaoka Y. Serum Helicobacter pylori CagA antibody as a biomarker for gastric cancer in east-Asian countries. Future Microbiol. 2010;5(12):1885–93. doi:10.2217/fmb.10.135.
   PubMed Web of Science ®Google Scholar
• Figueiredo C, Machado JC, Pharoah P, Seruca R, Sousa S, Carvalho R, Capelinha AF, Quint W, Caldas C, van Doorn LJ. et al. Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma. J Natl Cancer Inst. 2002;94(22):1680–1687. doi:10.1093/jnci/94.22.1680.
   PubMedGoogle Scholar
• Plummer M, van Doorn LJ, Franceschi S, Kleter B, Canzian F, Vivas J, Lopez G, Colin D, Munoz N, Kato I. Helicobacter pylori cytotoxin-associated genotype and gastric precancerous lesions. J Natl Cancer Inst. 2007;99(17):1328–1334. doi:10.1093/jnci/djm120.
   PubMedGoogle Scholar
• Basso D, Zambon CF, Letley DP, Stranges A, Marchet A, Rhead JL, Schiavon S, Guariso G, Ceroti M, Nitti D. et al. Clinical relevance of Helicobacter pylori cagA and vacA gene polymorphisms. Gastroenterology. 2008;135(1):91–9. doi:10.1053/j.gastro.2008.03.041.
   PubMed Web of Science ®Google Scholar
• Queiroz DM, Mendes EN, Rocha GA, Oliveira AM, Oliveira CA, Magalhaes PP, Moura SB, Cabral MM, Nogueira AM. cagA-positive Helicobacter pylori and risk for developing gastric carcinoma in Brazil. Int J Cancer. 1998;78:135–139.
   PubMed Web of Science ®Google Scholar
• Rugge M, Busatto G, Cassaro M, Shiao YH, Russo V, Leandro G, Avellini C, Fabiano A, Sidoni A, Covacci A. Patients younger than 40 years with gastric carcinoma: Helicobacter pylori genotype and associated gastritis phenotype. Cancer. 1999;85(12):2506–11. doi:10.1002/(SICI)1097-0142(19990615)85:12<2506:AID-CNCR3>3.0.CO;2-I.
   PubMed Web of Science ®Google Scholar
• Zambon CF, Navaglia F, Basso D, Rugge M, Plebani M. Helicobacter pylori babA2, cagA, and s1 vacA genes work synergistically in causing intestinal metaplasia. J Clin Pathol. 2003;56(4):287–291. doi:10.1136/jcp.56.4.287.
   PubMed Web of Science ®Google Scholar
• Oliveira AG, Santos A, Guerra JB, Rocha GA, Rocha AM, Oliveira CA, Cabral MM, Nogueira AM, Queiroz DM. babA2- and cagA-positive Helicobacter pylori strains are associated with duodenal ulcer and gastric carcinoma in Brazil. J Clin Microbiol. 2003;41(8):3964–3966. doi:10.1128/JCM.41.8.3964-3966.2003.
   PubMed Web of Science ®Google Scholar
• Rocha GA, Guerra JB, Rocha AM, Saraiva IE, da Silva DA, de Oliveira CA, Queiroz DM. IL1RN polymorphic gene and cagA-positive status independently increase the risk of noncardia gastric carcinoma. Int J Cancer. 2005;115(5):678–683. doi:10.1002/ijc.20935.
   PubMed Web of Science ®Google Scholar
• Quintero E, Pizarro MA, Rodrigo L, Pique JM, Lanas A, Ponce J, Mino G, Gisbert J, Jurado A, Herrero MJ. et al. Association of Helicobacter pylori-related distal gastric cancer with the HLA class II gene DQB1* 0602 and cagA + strains in a Southern European Population. Helicobacter. 2005;10(1):12–21. doi:10.1111/j.1523-5378.2005.00287.x.
   PubMed Web of Science ®Google Scholar
• Gonzalez CA, Figueiredo C, Lic BC, Ferreira RM, Pardo ML, Ruiz Liso JM, Alonso P, Sala N, Capella G, Sanz-Anquela JM. Helicobacter pylori cagA and vacA genotypes as predictors of progression of gastric preneoplastic lesions: a long-term follow-up in a high-risk area in Spain. Am J Gastroenterol. 2011;106(5):867–874. doi:10.1038/ajg.2011.1.
   PubMed Web of Science ®Google Scholar
• Matos JI, de Sousa HA, Marcos-Pinto R, Dinis-Ribeiro M. Helicobacter pylori CagA and VacA genotypes and gastric phenotype: a meta-analysis. Eur J Gastroenterol Hepatol. 2013;25(12):1431–1441. doi:10.1097/MEG.0b013e328364b53e.
   PubMed Web of Science ®Google Scholar
• Pormohammad A, Ghotaslou R, Leylabadlo HE, Nasiri MJ, Dabiri H, Hashemi A. Risk of gastric cancer in association with Helicobacter pylori different virulence factors: a systematic review and meta-analysis. Microb Pathog. 2018;118:214–219. doi:10.1016/j.micpath.2018.03.004.
   PubMed Web of Science ®Google Scholar
• van Doorn LJ, Figueiredo C, Sanna R, Plaisier A, Schneeberger P, de Boer W, Quint W. Clinical relevance of the cagA, vacA, and iceA status of Helicobacter pylori. Gastroenterology. 1998;115(1):58–66. doi:10.1016/S0016-5085(98)70365-8.
   PubMed Web of Science ®Google Scholar
• Van Doorn LJ, Figueiredo C, Megraud F, Pena S, Midolo P, Queiroz DM, Carneiro F, Vanderborght B, Pegado MD, Sanna R. et al. Geographic distribution of vacA allelic types of Helicobacter pylori. Gastroenterology. 1999;116(4):823–30. doi:10.1016/S0016-5085(99)70065-X.
   PubMed Web of Science ®Google Scholar
• Hamlet A, Thoreson AC, Nilsson O, Svennerholm AM, Olbe L. Duodenal Helicobacter pylori infection differs in cagA genotype between asymptomatic subjects and patients with duodenal ulcers. Gastroenterology. 1999;116(2):259–68. doi:10.1016/S0016-5085(99)70121-6.
   PubMed Web of Science ®Google Scholar
• Queiroz DM, Bittencourt P, Guerra JB, Rocha AM, Rocha GA, Carvalho AS. IL1RN polymorphism and cagA-positive Helicobacter pylori strains increase the risk of duodenal ulcer in children. Pediatr Res. 2005;58(5):892–6. doi:10.1203/01.PDR.0000181380.14230.8B.
   PubMed Web of Science ®Google Scholar
• Tham KT, Peek RM Jr., Atherton JC, Cover TL, Perez-Perez GI, Shyr Y, Blaser MJ. Helicobacter pylori genotypes, host factors, and gastric mucosal histopathology in peptic ulcer disease. Hum Pathol. 2001;32(3):264–73. doi:10.1053/hupa.2001.21136.
   PubMed Web of Science ®Google Scholar
• Nogueira C, Figueiredo C, Carneiro F, Gomes AT, Barreira R, Figueira P, Salgado C, Belo L, Peixoto A, Bravo JC. et al. Helicobacter pylori genotypes may determine gastric histopathology. Am J Pathol. 2001;158(2):647–54. doi:10.1016/S0002-9440(10)64006-0.
   PubMed Web of Science ®Google Scholar
• Kersulyte D, Chalkauskas H, Berg DE. Emergence of recombinant strains of Helicobacter pylori during human infection. Mol Microbiol. 1999;31(1):31–43. doi:10.1046/j.1365-2958.1999.01140.x.
   PubMed Web of Science ®Google Scholar
• Berthenet E, Yahara K, Thorell K, Pascoe B, Meric G, Mikhail JM, Engstrand L, Enroth H, Burette A, Megraud F. et al. A GWAS on Helicobacter pylori strains points to genetic variants associated with gastric cancer risk. BMC Biol. 2018;16(1):84. doi:10.1186/s12915-018-0550-3.
   PubMedGoogle Scholar
• Ito Y, Azuma T, Ito S, Miyaji H, Hirai M, Yamazaki Y, Sato F, Kato T, Kohli Y, Kuriyama M. Analysis and typing of the vacA gene from cagA-positive strains of Helicobacter pylori isolated in Japan. J Clin Microbiol. 1997;35(7):1710–4. doi:10.1128/jcm.35.7.1710-1714.1997.
   PubMed Web of Science ®Google Scholar
• Pan ZJ, van der Hulst RW, Feller M, Xiao SD, Tytgat GN, Dankert J, van der Ende A. Equally high prevalences of infection with cagA-positive Helicobacter pylori in Chinese patients with peptic ulcer disease and those with chronic gastritis-associated dyspepsia. J Clin Microbiol. 1997;35(6):1344–1347. doi:10.1128/jcm.35.6.1344-1347.1997.
   PubMed Web of Science ®Google Scholar
• Hansson LE, Nyren O, Hsing AW, Bergstrom R, Josefsson S, Chow WH, Fraumeni JF Jr., Adami HO. The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med. 1996;335(4):242–9. doi:10.1056/NEJM199607253350404.
   PubMed Web of Science ®Google Scholar
• Hayashi T, Senda M, Morohashi H, Higashi H, Horio M, Kashiba Y, Nagase L, Sasaya D, Shimizu T, Venugopalan N. et al. Tertiary structure-function analysis reveals the pathogenic signaling potentiation mechanism of Helicobacter pylori oncogenic effector CagA. Cell Host Microbe. 2012;12(1):20–33. doi:10.1016/j.chom.2012.05.010.
   PubMed Web of Science ®Google Scholar
• Kaplan-Turkoz B, Jimenez-Soto LF, Dian C, Ertl C, Remaut H, Louche A, Tosi T, Haas R, Terradot L. Structural insights into Helicobacter pylori oncoprotein CagA interaction with β1 integrin. Proc Natl Acad Sci USA. 2012;109(36):14640–14645. doi:10.1073/pnas.1206098109.
   PubMed Web of Science ®Google Scholar
• Schindele F, Weiss E, Haas R, Fischer W. Quantitative analysis of CagA type IV secretion by Helicobacter pylori reveals substrate recognition and translocation requirements. Mol Microbiol. 2016;100(1):188–203. doi:10.1111/mmi.13309.
   PubMed Web of Science ®Google Scholar
• Lettl C, Haas R, Fischer W. Kinetics of CagA type IV secretion by Helicobacter pylori and the requirement for substrate unfolding. Mol Microbiol. 2021;116(3):794–807. doi:10.1111/mmi.14772.
   PubMed Web of Science ®Google Scholar
• Ren S, Higashi H, Lu H, Azuma T, Hatakeyama M. Structural basis and functional consequence of Helicobacter pylori CagA multimerization in cells. J Biol Chem. 2006;281(43):32344–52. doi:10.1074/jbc.M606172200.
   PubMed Web of Science ®Google Scholar
• Nagase L, Murata-Kamiya N, Hatakeyama M. Potentiation of Helicobacter pylori CagA protein virulence through homodimerization. J Biol Chem. 2011;286(38):33622–31. doi:10.1074/jbc.M111.258673.
   PubMed Web of Science ®Google Scholar
• Stein M, Bagnoli F, Halenbeck R, Rappuoli R, Fantl WJ, Covacci A. C-Src/Lyn kinases activate Helicobacter pylori CagA through tyrosine phosphorylation of the EPIYA motifs. Mol Microbiol. 2002;43(4):971–80. doi:10.1046/j.1365-2958.2002.02781.x.
   PubMed Web of Science ®Google Scholar
• Selbach M, Moese S, Hauck CR, Meyer TF, Backert S. Src is the kinase of the Helicobacter pylori CagA protein in vitro and in vivo. J Biol Chem. 2002;277(9):6775–8. doi:10.1074/jbc.C100754200.
   PubMed Web of Science ®Google Scholar
• Poppe M, Feller SM, Romer G, Wessler S. Phosphorylation of Helicobacter pylori CagA by c-abl leads to cell motility. Oncogene. 2007;26(24):3462–72. doi:10.1038/sj.onc.1210139.
   PubMed Web of Science ®Google Scholar
• Tammer I, Brandt S, Hartig R, Konig W, Backert S. Activation of abl by Helicobacter pylori: a novel kinase for CagA and crucial mediator of host cell scattering. Gastroenterology. 2007;132(4):1309–19. doi:10.1053/j.gastro.2007.01.050.
   PubMed Web of Science ®Google Scholar
• Takahashi-Kanemitsu A, Knight CT, Hatakeyama M. Molecular anatomy and pathogenic actions of Helicobacter pylori CagA that underpin gastric carcinogenesis. Cell Mol Immunol. 2020;17(1):50–63. doi:10.1038/s41423-019-0339-5.
   PubMed Web of Science ®Google Scholar
• Tegtmeyer N, Neddermann M, Asche CI, Backert S. Subversion of host kinases: a key network in cellular signaling hijacked by Helicobacter pylori CagA. Mol Microbiol. 2017;105(3):358–372. doi:10.1111/mmi.13707.
   PubMed Web of Science ®Google Scholar
• Selbach M, Paul FE, Brandt S, Guye P, Daumke O, Backert S, Dehio C, Mann M. Host cell interactome of tyrosine-phosphorylated bacterial proteins. Cell Host Microbe. 2009;5(4):397–403. doi:10.1016/j.chom.2009.03.004.
   PubMed Web of Science ®Google Scholar
• Mimuro H, Suzuki T, Tanaka J, Asahi M, Haas R, Sasakawa C. Grb2 is a key mediator of Helicobacter pylori CagA protein activities. Mol Cell. 2002;10(4):745–55. doi:10.1016/S1097-2765(02)00681-0.
   PubMed Web of Science ®Google Scholar
• Suzuki M, Mimuro H, Suzuki T, Park M, Yamamoto T, Sasakawa C. Interaction of CagA with Crk plays an important role in Helicobacter pylori –induced loss of gastric epithelial cell adhesion. J Exp Med. 2005;202(9):1235–1247. doi:10.1084/jem.20051027.
   PubMed Web of Science ®Google Scholar
• Suzuki M, Mimuro H, Kiga K, Fukumatsu M, Ishijima N, Morikawa H, Nagai S, Koyasu S, Gilman RH, Kersulyte D. et al. Helicobacter pylori CagA phosphorylation-independent function in epithelial proliferation and inflammation. Cell Host Microbe. 2009;5(1):23–34. doi:10.1016/j.chom.2008.11.010.
   PubMed Web of Science ®Google Scholar
• Saadat I, Higashi H, Obuse C, Umeda M, Murata-Kamiya N, Saito Y, Lu H, Ohnishi N, Azuma T, Suzuki A. et al. Helicobacter pylori CagA targets PAR1/MARK kinase to disrupt epithelial cell polarity. Nature. 2007;447(7142):330–3. doi:10.1038/nature05765.
   PubMed Web of Science ®Google Scholar
• Buti L, Ruiz-Puig C, Sangberg D, Leissing TM, Brewer RC, Owen RP, Sgromo B, Royer C, Ebner D, Lu X. CagA–ASPP2 complex mediates loss of cell polarity and favors H. pylori colonization of human gastric organoids. Proc Natl Acad Sci U S A. 2020;117(5):2645–2655. doi:10.1073/pnas.1908787117.
   PubMed Web of Science ®Google Scholar
• Mueller D, Tegtmeyer N, Brandt S, Yamaoka Y, De Poire E, Sgouras D, Wessler S, Torres J, Smolka A, Backert S. C-src and c-Abl kinases control hierarchic phosphorylation and function of the CagA effector protein in Western and East Asian Helicobacter pylori strains. J Clin Invest. 2012;122(4):1553–66. doi:10.1172/JCI61143.
   PubMed Web of Science ®Google Scholar
• Argent RH, Kidd M, Owen RJ, Thomas RJ, Limb MC, Atherton JC. Determinants and consequences of different levels of CagA phosphorylation for clinical isolates of Helicobacter pylori. Gastroenterology. 2004;127(2):514–23. doi:10.1053/j.gastro.2004.06.006.
   PubMed Web of Science ®Google Scholar
• Naito M, Yamazaki T, Tsutsumi R, Higashi H, Onoe K, Yamazaki S, Azuma T, Hatakeyama M. Influence of EPIYA-repeat polymorphism on the phosphorylation-dependent biological activity of Helicobacter pylori CagA. Gastroenterology. 2006;130(4):1181–90. doi:10.1053/j.gastro.2005.12.038.
   PubMed Web of Science ®Google Scholar
• Li Q, Liu J, Gong Y, Yuan Y. Association of CagA EPIYA-D or EPIYA-C phosphorylation sites with peptic ulcer and gastric cancer risks: a meta-analysis. Medicine (Baltimore). 2017;96(17):e6620. doi:10.1097/MD.0000000000006620.
   PubMed Web of Science ®Google Scholar
• Fischer W. Assembly and molecular mode of action of the Helicobacter pylori Cag type IV secretion apparatus. FEBS J. 2011;278(8):1203–12. doi:10.1111/j.1742-4658.2011.08036.x.
   PubMed Web of Science ®Google Scholar
• Waksman G. From conjugation to T4S systems in Gram-negative bacteria: a mechanistic biology perspective. EMBO Rep. 2019;20(2):e47012. doi:10.15252/embr.201847012.
   PubMed Web of Science ®Google Scholar
• Costa TRD, Harb L, Khara P, Zeng L, Hu B, Christie PJ. Type IV secretion systems: advances in structure, function, and activation. Mol Microbiol. 2021;115(3):436–452. doi:10.1111/mmi.14670.
   PubMed Web of Science ®Google Scholar
• Galan JE, Waksman G. Protein-injection machines in bacteria. Cell. 2018;172(6):1306–1318. doi:10.1016/j.cell.2018.01.034.
   PubMed Web of Science ®Google Scholar
• Costa TRD, Patkowski JB, Mace K, Christie PJ, Waksman G. Structural and functional diversity of type IV secretion systems. Nat Rev Microbiol. 2023;1–6. doi:10.1038/s41579-023-00974-3.
   Web of Science ®Google Scholar
• Sheedlo MJ, Ohi MD, Lacy DB, Cover TL. Molecular architecture of bacterial type IV secretion systems. PloS Pathog. 2022;18(8):e1010720. doi:10.1371/journal.ppat.1010720.
   PubMed Web of Science ®Google Scholar
• Mace K, Vadakkepat AK, Redzej A, Lukoyanova N, Oomen C, Braun N, Ukleja M, Lu F, Costa TRD, Orlova EV. et al. Cryo-EM structure of a type IV secretion system. Nature. 2022;607(7917):191–196. doi:10.1038/s41586-022-04859-y.
   PubMed Web of Science ®Google Scholar
• Chang YW, Shaffer CL, Rettberg LA, Ghosal D, Jensen GJ. In vivo structures of the Helicobacter pylori cag type IV secretion system. Cell Rep. 2018;23(3):673–681. doi:10.1016/j.celrep.2018.03.085.
   PubMed Web of Science ®Google Scholar
• Hu B, Khara P, Song L, Lin AS, Frick-Cheng AE, Harvey ML, Cover TL, Christie PJ . In situ molecular architecture of the Helicobacter pylori Cag Type IV Secretion System. MBio. 2019;10(3):10–128. doi:10.1128/mBio.00849-19.
   Web of Science ®Google Scholar
• Frick-Cheng AE, Pyburn TM, Voss BJ, McDonald WH, Ohi MD, Cover TL. Molecular and structural analysis of the Helicobacter pylori cag type IV secretion system core complex. MBio. 2016;7(1):e02001–15. doi:10.1128/mBio.02001-15.
   PubMed Web of Science ®Google Scholar
• Tran SC, McClain MS, Cover TL. Role of the CagY antenna projection in Helicobacter pylori cag type IV secretion system activity. Infect Immun. 2023;91(9):e0015023. doi:10.1128/iai.00150-23.
   PubMedGoogle Scholar
• Lin AS, Dooyema SDR, Frick-Cheng AE, Harvey ML, Suarez G, Loh JT, McDonald WH, McClain MS, Peek RM Jr., Cover TL. Bacterial energetic requirements for Helicobacter pylori Cag type IV secretion system-dependent alterations in gastric epithelial cells. Infect Immun. 2020;88(2):10–128. doi:10.1128/IAI.00790-19.
   Web of Science ®Google Scholar
• Couturier MR, Tasca E, Montecucco C, Stein M. Interaction with CagF is required for translocation of CagA into the host via the Helicobacter pylori type IV secretion system. Infect Immun. 2006;74(1):273–81. doi:10.1128/IAI.74.1.273-281.2006.
   PubMed Web of Science ®Google Scholar
• Pattis I, Weiss E, Laugks R, Haas R, Fischer W. The Helicobacter pylori CagF protein is a type IV secretion chaperone-like molecule that binds close to the C-terminal secretion signal of the CagA effector protein. Microbiology. 2007;153(9):2896–909. doi:10.1099/mic.0.2007/007385-0.
   PubMedGoogle Scholar
• Bonsor DA, Weiss E, Iosub-Amir A, Reingewertz TH, Chen TW, Haas R, Friedler A, Fischer W, Sundberg EJ. Characterization of the translocation-competent complex between the Helicobacter pylori oncogenic protein CagA and the accessory protein CagF. J Biol Chem. 2013;288(46):32897–909. doi:10.1074/jbc.M113.507657.
   PubMed Web of Science ®Google Scholar
• Shaffer CL, Gaddy JA, Loh JT, Johnson EM, Hill S, Hennig EE, McClain MS, McDonald WH, Cover TL. Helicobacter pylori exploits a unique repertoire of type IV secretion system components for pilus assembly at the bacteria-host cell interface. PloS Pathog. 2011;7(9):e1002237. doi:10.1371/journal.ppat.1002237.
   PubMed Web of Science ®Google Scholar
• Pham KT, Weiss E, Jimenez Soto LF, Breithaupt U, Haas R, Fischer W. CagI is an essential component of the Helicobacter pylori Cag type IV secretion system and forms a complex with CagL. PloS ONE. 2012;7(4):e35341. doi:10.1371/journal.pone.0035341.
   PubMed Web of Science ®Google Scholar
• Kwok T, Zabler D, Urman S, Rohde M, Hartig R, Wessler S, Misselwitz R, Berger J, Sewald N, Konig W. et al. Helicobacter exploits integrin for type IV secretion and kinase activation. Nature. 2007;449(7164):862–6. doi:10.1038/nature06187.
   PubMed Web of Science ®Google Scholar
• Andrzejewska J, Lee SK, Olbermann P, Lotzing N, Katzowitsch E, Linz B, Achtman M, Kado CI, Suerbaum S, Josenhans C. Characterization of the pilin ortholog of the Helicobacter pylori type IV cag pathogenicity apparatus, a surface-associated protein expressed during infection. J Bacteriol. 2006;188(16):5865–77. doi:10.1128/JB.00060-06.
   PubMed Web of Science ®Google Scholar
• Blanc M, Lettl C, Guerin J, Vieille A, Furler S, Briand-Schumacher S, Dreier B, Berge C, Pluckthun A, Vadon-Le Goff S. et al. Designed ankyrin repeat proteins provide insights into the structure and function of CagI and are potent inhibitors of CagA translocation by the Helicobacter pylori type IV secretion system. PloS Pathog. 2023;19(5):e1011368. doi:10.1371/journal.ppat.1011368.
   PubMed Web of Science ®Google Scholar
• Backert S, Fronzes R, Waksman G. VirB2 and VirB5 proteins: specialized adhesins in bacterial type-IV secretion systems? Trends Microbiol. 2008;16(9):409–13. doi:10.1016/j.tim.2008.07.001.
   PubMed Web of Science ®Google Scholar
• Rohde M, Puls J, Buhrdorf R, Fischer W, Haas R. A novel sheathed surface organelle of the Helicobacter pylori cag type IV secretion system. Mol Microbiol. 2003;49(1):219–34. doi:10.1046/j.1365-2958.2003.03549.x.
   PubMed Web of Science ®Google Scholar
• Kaplan M, Chreifi G, Metskas LA, Liedtke J, Wood CR, Oikonomou CM, Nicolas WJ, Subramanian P, Zacharoff LA, Wang Y. et al. In situ imaging of bacterial outer membrane projections and associated protein complexes using electron cryo-tomography. Elife. 2021;10:e73099. doi:10.7554/eLife.73099.
   PubMed Web of Science ®Google Scholar
• Wallden K, Rivera-Calzada A, Waksman G. Microreview: type IV secretion systems: versatility and diversity in function. Cell Microbiol. 2010;12(9):1203–12. doi:10.1111/j.1462-5822.2010.01499.x.
   PubMed Web of Science ®Google Scholar
• Christie PJ, Gomez Valero L, Buchrieser C. Biological diversity and evolution of type IV secretion systems. Curr Top Microbiol Immunol. 2017;413:1–30.
   PubMed Web of Science ®Google Scholar
• Hohlfeld S, Pattis I, Puls J, Plano GV, Haas R, Fischer W. A C-terminal translocation signal is necessary, but not sufficient for type IV secretion of the Helicobacter pylori CagA protein. Mol Microbiol. 2006;59(5):1624–37. doi:10.1111/j.1365-2958.2006.05050.x.
   PubMed Web of Science ®Google Scholar
• Wu X, Zhao Y, Zhang H, Yang W, Yang J, Sun L, Jiang M, Wang Q, Wang Q, Ye X. et al. Mechanism of regulation of the Helicobacter pylori Cagβ ATPase by CagZ. Nat Commun. 2023;14(1):479. doi:10.1038/s41467-023-36218-4.
   PubMed Web of Science ®Google Scholar
• Kutter S, Buhrdorf R, Haas J, Schneider-Brachert W, Haas R, Fischer W. Protein subassemblies of the Helicobacter pylori Cag type IV secretion system revealed by localization and interaction studies. J Bacteriol. 2008;190(6):2161–2171. doi:10.1128/JB.01341-07.
   PubMed Web of Science ®Google Scholar
• Jurik A, Hausser E, Kutter S, Pattis I, Prassl S, Weiss E, Fischer W. The coupling protein Cagβ and its interaction partner CagZ are required for type IV secretion of the Helicobacter pylori CagA protein. Infect Immun. 2010;78(12):5244–5251. doi:10.1128/IAI.00796-10.
   PubMed Web of Science ®Google Scholar
• Jimenez-Soto LF, Kutter S, Sewald X, Ertl C, Weiss E, Kapp U, Rohde M, Pirch T, Jung K, Retta SF. et al. Helicobacter pylori type IV secretion apparatus exploits β1 Integrin in a novel RGD-Independent manner. PloS Pathog. 2009;5(12):e1000684. doi:10.1371/journal.ppat.1000684.
   PubMed Web of Science ®Google Scholar
• Buss M, Tegtmeyer N, Schnieder J, Dong X, Li J, Springer TA, Backert S, Niemann HH. Specific high affinity interaction of Helicobacter pylori CagL with integrin α Vβ 6 promotes type IV secretion of CagA into human cells. FEBS J. 2019;286(20):3980–3997. doi:10.1111/febs.14962.
   PubMed Web of Science ®Google Scholar
• Tegtmeyer N, Wessler S, Necchi V, Rohde M, Harrer A, Rau TT, Asche CI, Boehm M, Loessner H, Figueiredo C. et al. Helicobacter pylori employs a unique basolateral type IV secretion mechanism for CagA delivery. Cell Host Microbe. 2017;22(4):552–560.e5. doi:10.1016/j.chom.2017.09.005.
   PubMed Web of Science ®Google Scholar
• Sharafutdinov I, Tegtmeyer N, Linz B, Rohde M, Vieth M, Tay AC, Lamichhane B, Tuan VP, Fauzia KA, Sticht H. et al. A single-nucleotide polymorphism in Helicobacter pylori promotes gastric cancer development. Cell Host Microbe. 2023;31(8):1345–1358.e6. doi:10.1016/j.chom.2023.06.016.
   PubMed Web of Science ®Google Scholar
• Murata-Kamiya N, Kikuchi K, Hayashi T, Higashi H, Hatakeyama M. Helicobacter pylori exploits host membrane phosphatidylserine for delivery, localization, and pathophysiological action of the CagA oncoprotein. Cell Host Microbe. 2010;7(5):399–411. doi:10.1016/j.chom.2010.04.005.
   PubMed Web of Science ®Google Scholar
• Bagnoli F, Buti L, Tompkins L, Covacci A, Amieva MR. Helicobacter pylori CagA induces a transition from polarized to invasive phenotypes in MDCK cells. Proc Natl Acad Sci USA. 2005;102(45):16339–16344. doi:10.1073/pnas.0502598102.
   PubMed Web of Science ®Google Scholar
• Churin Y, Al-Ghoul L, Kepp O, Meyer TF, Birchmeier W, Naumann M. Helicobacter pylori CagA protein targets the c-Met receptor and enhances the motogenic response. J Cell Biol. 2003;161(2):249–55. doi:10.1083/jcb.200208039.
   PubMed Web of Science ®Google Scholar
• Lee DG, Kim HS, Lee YS, Kim S, Cha SY, Ota I, Kim NH, Cha YH, Yang DH, Lee Y. et al. Helicobacter pylori CagA promotes Snail-mediated epithelial–mesenchymal transition by reducing GSK-3 activity. Nat Commun. 2014;5(1):4423. doi:10.1038/ncomms5423.
   PubMedGoogle Scholar
• Backert S, Moese S, Selbach M, Brinkmann V, Meyer TF. Phosphorylation of tyrosine 972 of the Helicobacter pylori CagA protein is essential for induction of a scattering phenotype in gastric epithelial cells. Mol Microbiol. 2001;42(3):631–44. doi:10.1046/j.1365-2958.2001.02649.x.
   PubMed Web of Science ®Google Scholar
• Amieva MR, Vogelmann R, Covacci A, Tompkins LS, Nelson WJ, Falkow S. Disruption of the epithelial apical-junctional complex by Helicobacter pylori CagA. Science. 2003;300(5624):1430–4. doi:10.1126/science.1081919.
   PubMed Web of Science ®Google Scholar
• Higashi H, Tsutsumi R, Muto S, Sugiyama T, Azuma T, Asaka M, Hatakeyama M. SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science. 2002;295(5555):683–6. doi:10.1126/science.1067147.
   PubMed Web of Science ®Google Scholar
• Tsutsumi R, Higashi H, Higuchi M, Okada M, Hatakeyama M. Attenuation of Helicobacter pylori CagA·SHP-2 signaling by interaction between CagA and C-terminal Src Kinase. J Biol Chem. 2003;278(6):3664–3670. doi:10.1074/jbc.M208155200.
   PubMed Web of Science ®Google Scholar
• Nesic D, Miller MC, Quinkert ZT, Stein M, Chait BT, Stebbins CE. Helicobacter pylori CagA inhibits PAR1-MARK family kinases by mimicking host substrates. Nat Struct Mol Biol. 2010;17(1):130–132. doi:10.1038/nsmb.1705.
   PubMed Web of Science ®Google Scholar
• Lu H, Murata-Kamiya N, Saito Y, Hatakeyama M. Role of partitioning-defective 1/Microtubule affinity-regulating kinases in the morphogenetic activity of Helicobacter pylori CagA. J Biol Chem. 2009;284(34):23024–23036. doi:10.1074/jbc.M109.001008.
   PubMed Web of Science ®Google Scholar
• Murata-Kamiya N, Kurashima Y, Teishikata Y, Yamahashi Y, Saito Y, Higashi H, Aburatani H, Akiyama T, Peek RM Jr., Azuma T. et al. Helicobacter pylori CagA interacts with E-cadherin and deregulates the β-catenin signal that promotes intestinal transdifferentiation in gastric epithelial cells. Oncogene. 2007;26(32):4617–4626. doi:10.1038/sj.onc.1210251.
   PubMed Web of Science ®Google Scholar
• Oliveira MJ, Costa AM, Costa AC, Ferreira RM, Sampaio P, Machado JC, Seruca R, Mareel M, Figueiredo C. CagA associates with c-met, E-Cadherin, and p120-catenin in a multiproteic complex that suppresses Helicobacter pylori–induced Cell-Invasive Phenotype. J Infect Dis. 2009;200(5):745–755. doi:10.1086/604727.
   PubMed Web of Science ®Google Scholar
• Franco AT, Israel DA, Washington MK, Krishna U, Fox JG, Rogers AB, Neish AS, Collier-Hyams L, Perez-Perez GI, Hatakeyama M. et al. Activation of β-catenin by carcinogenic Helicobacter pylori. Proc Natl Acad Sci U S A. 2005;102(30):10646–10651. doi:10.1073/pnas.0504927102.
   PubMed Web of Science ®Google Scholar
• Takahashi-Kanemitsu A, Lu M, Knight CT, Yamamoto T, Hayashi T, Mii Y, Ooki T, Kikuchi I, Kikuchi A, Barker N. et al. The Helicobacter pylori CagA oncoprotein disrupts Wnt/PCP signaling and promotes hyperproliferation of pyloric gland base cells. Sci Signal. 2023;16(794):eabp9020. doi:10.1126/scisignal.abp9020.
   PubMed Web of Science ®Google Scholar
• Nesic D, Buti L, Lu X, Stebbins CE. Structure of the Helicobacter pylori CagA oncoprotein bound to the human tumor suppressor ASPP2. Proc Natl Acad Sci U S A. 2014;111(4):1562–1567. doi:10.1073/pnas.1320631111.
   PubMed Web of Science ®Google Scholar
• Buti L, Spooner E, Van der Veen AG, Rappuoli R, Covacci A, Ploegh HL. Helicobacter pylori cytotoxin-associated gene a (CagA) subverts the apoptosis-stimulating protein of p53 (ASPP2) tumor suppressor pathway of the host. Proc Natl Acad Sci U S A. 2011;108(22):9238–9243. doi:10.1073/pnas.1106200108.
   PubMed Web of Science ®Google Scholar
• Wei J, Nagy TA, Vilgelm A, Zaika E, Ogden SR, Romero-Gallo J, Piazuelo MB, Correa P, Washington MK, El-Rifai W. et al. Regulation of p53 tumor suppressor by Helicobacter pylori in gastric epithelial cells. Gastroenterology. 2010;139(4):1333–1343.e4. doi:10.1053/j.gastro.2010.06.018.
   PubMed Web of Science ®Google Scholar
• Wei J, Noto JM, Zaika E, Romero-Gallo J, Piazuelo MB, Schneider B, El-Rifai W, Correa P, Peek RM, Zaika AI. Bacterial CagA protein induces degradation of p53 protein in a p14ARF-dependent manner. Gut. 2015;64(7):1040–8. doi:10.1136/gutjnl-2014-307295.
   PubMed Web of Science ®Google Scholar
• Chaturvedi R, Asim M, Romero-Gallo J, Barry DP, Hoge S, de Sablet T, Delgado AG, Wroblewski LE, Piazuelo MB, Yan F. et al. Spermine oxidase mediates the gastric cancer risk associated with Helicobacter pylori CagA. Gastroenterology. 2011;141(5):1696–1708.e2. doi:10.1053/j.gastro.2011.07.045.
   PubMed Web of Science ®Google Scholar
• Zamperone A, Cohen D, Stein M, Viard C, Musch A. Inhibition of polarity-regulating kinase PAR1b contributes to Helicobacter pylori inflicted DNA double strand breaks in gastric cells. Cell Cycle. 2019;18(3):299–311. doi:10.1080/15384101.2018.1560121.
   PubMed Web of Science ®Google Scholar
• Murata-Kamiya N, Hatakeyama M. Helicobacter pylori-induced DNA double-stranded break in the development of gastric cancer. Cancer Sci. 2022;113(6):1909–1918. doi:10.1111/cas.15357.
   PubMed Web of Science ®Google Scholar
• Imai S, Ooki T, Murata-Kamiya N, Komura D, Tahmina K, Wu W, Takahashi-Kanemitsu A, Knight CT, Kunita A, Suzuki N. et al. Helicobacter pylori CagA elicits BRCAness to induce genome instability that may underlie bacterial gastric carcinogenesis. Cell Host Microbe. 2021;29(6):941–958.e10. doi:10.1016/j.chom.2021.04.006.
   PubMed Web of Science ®Google Scholar
• Kolinjivadi AM, Sankar H, Choudhary R, Tay LS, Tan TZ, Murata-Kamiya N, Voon DC, Kappei D, Hatakeyama M, Krishnan V. et al. The H. pylori CagA oncoprotein induces DNA double strand breaks through fanconi anemia pathway downregulation and replication fork collapse. Int J Mol Sci. 2022;23(3):1661. doi:10.3390/ijms23031661.
   PubMed Web of Science ®Google Scholar
• Segal ED, Lange C, Covacci A, Tompkins LS, Falkow S. Induction of host signal transduction pathways by Helicobacter pylori. Proc Natl Acad Sci U S A. 1997;94(14):7595–7599. doi:10.1073/pnas.94.14.7595.
   PubMed Web of Science ®Google Scholar
• Brandt S, Kwok T, Hartig R, Konig W, Backert S. NF-κB activation and potentiation of proinflammatory responses by the Helicobacter pylori CagA protein. Proc Natl Acad Sci U S A. 2005;102(26):9300–9305. doi:10.1073/pnas.0409873102.
   PubMed Web of Science ®Google Scholar
• Stein SC, Faber E, Bats SH, Murillo T, Speidel Y, Coombs N, Josenhans C. Helicobacter pylori modulates host cell responses by CagT4SS-dependent translocation of an intermediate metabolite of LPS inner core heptose biosynthesis. PloS Pathog. 2017;13(7):e1006514. doi:10.1371/journal.ppat.1006514.
   PubMed Web of Science ®Google Scholar
• Zimmermann S, Pfannkuch L, Al-Zeer MA, Bartfeld S, Koch M, Liu J, Rechner C, Soerensen M, Sokolova O, Zamyatina A. et al. ALPK1- and TIFA-Dependent innate immune response triggered by the Helicobacter pylori type IV secretion system. Cell Rep. 2017;20(10):2384–2395. doi:10.1016/j.celrep.2017.08.039.
   PubMed Web of Science ®Google Scholar
• Gall A, Gaudet RG, Gray-Owen SD, Salama NR. TIFA signaling in gastric epithelial cells initiates the cag type 4 secretion system-dependent innate immune response to Helicobacter pylori infection. MBio. 2017;8(4). doi:10.1128/mBio.01168-17.
   Web of Science ®Google Scholar
• Gaudet RG, Sintsova A, Buckwalter CM, Leung N, Cochrane A, Li J, Cox AD, Moffat J, Gray-Owen SD. Cytosolic detection of the bacterial metabolite HBP activates TIFA-dependent innate immunity. Science. 2015;348(6240):1251–5. doi:10.1126/science.aaa4921.
   PubMed Web of Science ®Google Scholar
• Milivojevic M, Dangeard AS, Kasper CA, Tschon T, Emmenlauer M, Pique C, Schnupf P, Guignot J, Arrieumerlou C, Philpott DJ. ALPK1 controls TIFA/TRAF6-dependent innate immunity against heptose-1,7-bisphosphate of gram-negative bacteria. PloS Pathog. 2017;13(2):e1006224. doi:10.1371/journal.ppat.1006224.
   PubMed Web of Science ®Google Scholar
• Zhou P, She Y, Dong N, Li P, He H, Borio A, Wu Q, Lu S, Ding X, Cao Y. et al. Alpha-kinase 1 is a cytosolic innate immune receptor for bacterial ADP-heptose. Nature. 2018;561(7721):122–126. doi:10.1038/s41586-018-0433-3.
   PubMed Web of Science ®Google Scholar
• Pfannkuch L, Hurwitz R, Traulsen J, Sigulla J, Poeschke M, Matzner L, Kosma P, Schmid M, Meyer TF. ADP heptose, a novel pathogen-associated molecular pattern identified in Helicobacter pylori. FASEB J. 2019;33(8):9087–9099. doi:10.1096/fj.201802555R.
   PubMed Web of Science ®Google Scholar
• Bauer M, Nascakova Z, Mihai AI, Cheng PF, Levesque MP, Lampart S, Hurwitz R, Pfannkuch L, Dobrovolna J, Jacobs M. et al. The ALPK1/TIFA/NF-κB axis links a bacterial carcinogen to R-loop-induced replication stress. Nat Commun. 2020;11(1):5117. doi:10.1038/s41467-020-18857-z.
   PubMed Web of Science ®Google Scholar
• Viala J, Chaput C, Boneca IG, Cardona A, Girardin SE, Moran AP, Athman R, Memet S, Huerre MR, Coyle AJ. et al. Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat Immunol. 2004;5(11):1166–74. doi:10.1038/ni1131.
   PubMed Web of Science ®Google Scholar
• Varga MG, Shaffer CL, Sierra JC, Suarez G, Piazuelo MB, Whitaker ME, Romero-Gallo J, Krishna US, Delgado A, Gomez MA. et al. Pathogenic Helicobacter pylori strains translocate DNA and activate TLR9 via the cancer-associated cag type IV secretion system. Oncogene. 2016;35(48):6262–6269. doi:10.1038/onc.2016.158.
   PubMed Web of Science ®Google Scholar
• Damke PP, Wood CR, Shaffer CL. Helicobacter pylori provokes STING immunosurveillance via trans-kingdom conjugation. bioRxiv. 2022;2022–06.
   Google Scholar
• Varga MG, Piazuelo MB, Romero-Gallo J, Delgado AG, Suarez G, Whitaker ME, Krishna US, Patel RV, Skaar EP, Wilson KT. et al. TLR9 activation suppresses inflammation in response to Helicobacter pylori infection. Am J Physiol Gastrointest Liver Physiol. 2016;311(5):G852–G858. doi:10.1152/ajpgi.00175.2016.
   PubMed Web of Science ®Google Scholar
• Belogolova E, Bauer B, Pompaiah M, Asakura H, Brinkman V, Ertl C, Bartfeld S, Nechitaylo TY, Haas R, Machuy N. et al. Helicobacter pylori outer membrane protein HopQ identified as a novel T4SS-associated virulence factor. Cell Microbiol. 2013;15:1896–912. doi:10.1111/cmi.12158.
   PubMed Web of Science ®Google Scholar
• Koniger V, Holsten L, Harrison U, Busch B, Loell E, Zhao Q, Bonsor DA, Roth A, Kengmo-Tchoupa A, Smith SI. et al. Helicobacter pylori exploits human CEACAMs via HopQ for adherence and translocation of CagA. Nat Microbiol. 2016;2(1):16188. doi:10.1038/nmicrobiol.2016.188.
   PubMed Web of Science ®Google Scholar
• Javaheri A, Kruse T, Moonens K, Mejias-Luque R, Debraekeleer A, Asche CI, Tegtmeyer N, Kalali B, Bach NC, Sieber SA. et al. Helicobacter pylori adhesin HopQ engages in a virulence-enhancing interaction with human CEACAMs. Nat Microbiol. 2016;2(1):16189. doi:10.1038/nmicrobiol.2016.189.
   PubMed Web of Science ®Google Scholar
• Zhao Q, Busch B, Jimenez-Soto LF, Ishikawa-Ankerhold H, Massberg S, Terradot L, Fischer W, Haas R. Integrin but not CEACAM receptors are dispensable for Helicobacter pylori CagA translocation. PloS Pathog. 2018;14(10):e1007359. doi:10.1371/journal.ppat.1007359.
   PubMed Web of Science ®Google Scholar
• Ishijima N, Suzuki M, Ashida H, Ichikawa Y, Kanegae Y, Saito I, Boren T, Haas R, Sasakawa C, Mimuro H. BabA-mediated adherence is a potentiator of the Helicobacter pylori type IV secretion system activity. J Biol Chem. 2011;286(28):25256–64. doi:10.1074/jbc.M111.233601.
   PubMed Web of Science ®Google Scholar
• Lu H, Wu JY, Beswick EJ, Ohno T, Odenbreit S, Haas R, Reyes VE, Kita M, Graham DY, Yamaoka Y. Functional and intracellular signaling differences associated with the Helicobacter pylori AlpAB adhesin from Western and East Asian strains. J Biol Chem. 2007;282(9):6242–54. doi:10.1074/jbc.M611178200.
   PubMed Web of Science ®Google Scholar
• Wang G, Romero-Gallo J, Benoit SL, Piazuelo MB, Dominguez RL, Morgan DR, Peek RM Jr., Maier RJ. Hydrogen metabolism in Helicobacter pylori plays a Role in Gastric Carcinogenesis through facilitating CagA translocation. MBio. 2016;7(4). doi:10.1128/mBio.01022-16.
   Web of Science ®Google Scholar
• Varga MG, Wood CR, Butt J, Ryan ME, You WC, Pan K, Waterboer T, Epplein M, Shaffer CL. Immunostimulatory membrane proteins potentiate H. pylori-induced carcinogenesis by enabling CagA translocation. Gut Microbes. 2021;13(1):1–13. doi:10.1080/19490976.2020.1862613.
   PubMed Web of Science ®Google Scholar
• Gorrell RJ, Guan J, Xin Y, Tafreshi MA, Hutton ML, McGuckin MA, Ferrero RL, Kwok T. A novel NOD1- and CagA-independent pathway of interleukin-8 induction mediated by the Helicobacter pylori type IV secretion system. Cell Microbiol. 2013;15(4):554–70. doi:10.1111/cmi.12055.
   PubMed Web of Science ®Google Scholar
• Gewirtz AT, Yu Y, Krishna US, Israel DA, Lyons SL, Peek RM Jr. Helicobacter pylori Flagellin Evades Toll-Like Receptor 5–Mediated Innate Immunity. J Infect Dis. 2004;189(10):1914–1920. doi:10.1086/386289.
   PubMed Web of Science ®Google Scholar
• Andersen-Nissen E, Smith KD, Strobe KL, Barrett SL, Cookson BT, Logan SM, Aderem A. Evasion of Toll-like receptor 5 by flagellated bacteria. Proc Natl Acad Sci U S A. 2005;102(26):9247–9252. doi:10.1073/pnas.0502040102.
   PubMed Web of Science ®Google Scholar
• Pachathundikandi SK, Tegtmeyer N, Arnold IC, Lind J, Neddermann M, Falkeis-Veits C, Chattopadhyay S, Bronstrup M, Tegge W, Hong M. et al. T4SS-dependent TLR5 activation by Helicobacter pylori infection. Nat Commun. 2019;10(1):5717. doi:10.1038/s41467-019-13506-6.
   PubMedGoogle Scholar
• Tegtmeyer N, Neddermann M, Lind J, Pachathundikandi SK, Sharafutdinov I, Gutierrez-Escobar AJ, Bronstrup M, Tegge W, Hong M, Rohde M. et al. Toll-like receptor 5 activation by the CagY repeat domains of Helicobacter pylori. Cell Rep. 2020;32(11):108159. doi:10.1016/j.celrep.2020.108159.
   PubMed Web of Science ®Google Scholar
• Ohnishi N, Yuasa H, Tanaka S, Sawa H, Miura M, Matsui A, Higashi H, Musashi M, Iwabuchi K, Suzuki M. et al. Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse. Proc Natl Acad Sci U S A. 2008;105(3):1003–1008. doi:10.1073/pnas.0711183105.
   PubMed Web of Science ®Google Scholar
• Neal JT, Peterson TS, Kent ML, Guillemin K. H. pylori virulence factor CagA increases intestinal cell proliferation by Wnt pathway activation in a transgenic zebrafish model. Dis Model Mech. 2013;6:802–10. doi:10.1242/dmm.011163.
   PubMed Web of Science ®Google Scholar
• Botham CM, Wandler AM, Guillemin K. A transgenic Drosophila model demonstrates that the Helicobacter pylori CagA protein functions as a eukaryotic gab adaptor. PloS Pathog. 2008;4(5):e1000064. doi:10.1371/journal.ppat.1000064.
   PubMed Web of Science ®Google Scholar
• Wandler AM, Guillemin K. Transgenic expression of the Helicobacter pylori virulence factor CagA promotes apoptosis or tumorigenesis through JNK activation in Drosophila. PloS Pathog. 2012;8(10):e1002939. doi:10.1371/journal.ppat.1002939.
   PubMed Web of Science ®Google Scholar
• Jones TA, Hernandez DZ, Wong ZC, Wandler AM, Guillemin K. The bacterial virulence factor CagA induces microbial dysbiosis that contributes to excessive epithelial cell proliferation in the drosophila gut. PloS Pathog. 2017;13(10):e1006631. doi:10.1371/journal.ppat.1006631.
   PubMed Web of Science ®Google Scholar
• Hansen LM, Dekalb DJ, Cai LP, Solnick JV. Identification of Pathogenicity Island Genes Associated with loss of type IV secretion function during murine infection with Helicobacter pylori. Infect Immun. 2020;88(6). doi:10.1128/IAI.00801-19.
   PubMed Web of Science ®Google Scholar
• Shrestha R, Murata-Kamiya N, Imai S, Yamamoto M, Tsukamoto T, Nomura S, Hatakeyama M. Mouse gastric epithelial cells resist CagA delivery by the Helicobacter pylori type IV secretion system. Int J Mol Sci. 2022;23(5):2492. doi:10.3390/ijms23052492.
   PubMed Web of Science ®Google Scholar
• Arnold IC, Lee JY, Amieva MR, Roers A, Flavell RA, Sparwasser T, Muller A. Tolerance rather than immunity protects from Helicobacter pylori–induced gastric preneoplasia. Gastroenterology. 2011;140(1):199–209.e8. doi:10.1053/j.gastro.2010.06.047.
   PubMed Web of Science ®Google Scholar
• Wroblewski LE, Choi E, Petersen C, Delgado AG, Piazuelo MB, Romero-Gallo J, Lantz TL, Zavros Y, Coffey RJ, Goldenring JR. et al. Targeted mobilization of Lrig1 + gastric epithelial stem cell populations by a carcinogenic Helicobacter pylori type IV secretion system. Proc Natl Acad Sci U S A. 2019;116(39):19652–19658. doi:10.1073/pnas.1903798116.
   PubMed Web of Science ®Google Scholar
• Sigal M, Rothenberg ME, Logan CY, Lee JY, Honaker RW, Cooper RL, Passarelli B, Camorlinga M, Bouley DM, Alvarez G. et al. Helicobacter pylori activates and expands Lgr5+ stem cells through direct colonization of the gastric glands. Gastroenterology. 2015;148(7):1392–1404.e21. doi:10.1053/j.gastro.2015.02.049.
   PubMed Web of Science ®Google Scholar
• Fox JG, Wang TC, Rogers AB, Poutahidis T, Ge Z, Taylor N, Dangler CA, Israel DA, Krishna U, Gaus K. et al. Host and microbial constituents influence Helicobacter pylori-induced cancer in a murine model of hypergastrinemia. Gastroenterology. 2003;124(7):1879–90. doi:10.1016/S0016-5085(03)00406-2.
   PubMed Web of Science ®Google Scholar
• Ogura K, Maeda S, Nakao M, Watanabe T, Tada M, Kyutoku T, Yoshida H, Shiratori Y, Omata M. Virulence factors of Helicobacter pylori responsible for gastric diseases in mongolian gerbil. J Exp Med. 2000;192(11):1601–10. doi:10.1084/jem.192.11.1601.
   PubMed Web of Science ®Google Scholar
• Rieder G, Merchant JL, Haas R. Helicobacter pylori cag-type IV secretion system facilitates corpus colonization to induce precancerous conditions in Mongolian gerbils. Gastroenterology. 2005;128(5):1229–42. doi:10.1053/j.gastro.2005.02.064.
   PubMed Web of Science ®Google Scholar
• Shibata W, Hirata Y, Maeda S, Ogura K, Ohmae T, Yanai A, Mitsuno Y, Yamaji Y, Okamoto M, Yoshida H. et al. CagA protein secreted by the intact type IV secretion system leads to gastric epithelial inflammation in the Mongolian gerbil model. J Pathol. 2006;210(3):306–14. doi:10.1002/path.2040.
   PubMed Web of Science ®Google Scholar
• Mimuro H, Suzuki T, Nagai S, Rieder G, Suzuki M, Nagai T, Fujita Y, Nagamatsu K, Ishijima N, Koyasu S. et al. Helicobacter pylori dampens gut epithelial self-renewal by inhibiting apoptosis, a bacterial strategy to enhance colonization of the stomach. Cell Host Microbe. 2007;2(4):250–63. doi:10.1016/j.chom.2007.09.005.
   PubMed Web of Science ®Google Scholar
• Franco AT, Johnston E, Krishna U, Yamaoka Y, Israel DA, Nagy TA, Wroblewski LE, Piazuelo MB, Correa P, Peek RM Jr. Regulation of gastric carcinogenesis by Helicobacter pylori virulence factors. Cancer Res. 2008;68(2):379–87. doi:10.1158/0008-5472.CAN-07-0824.
   PubMed Web of Science ®Google Scholar
• Wiedemann T, Loell E, Mueller S, Stoeckelhuber M, Stolte M, Haas R, Rieder G. Helicobacter pylori cag-pathogenicity island-dependent early immunological response triggers later precancerous gastric changes in Mongolian gerbils. PloS ONE. 2009;4(3):e4754. doi:10.1371/journal.pone.0004754.
   PubMed Web of Science ®Google Scholar
• Gaddy JA, Radin JN, Loh JT, Zhang F, Washington MK, Peek RM Jr., Algood HM, Cover TL. High dietary salt intake exacerbates Helicobacter pylori-induced gastric carcinogenesis. Infect Immun. 2013;81(6):2258–67. doi:10.1128/IAI.01271-12.
   PubMed Web of Science ®Google Scholar
• Noto JM, Gaddy JA, Lee JY, Piazuelo MB, Friedman DB, Colvin DC, Romero-Gallo J, Suarez G, Loh J, Slaughter JC. et al. Iron deficiency accelerates Helicobacter pylori–induced carcinogenesis in rodents and humans. J Clin Invest. 2013;123(1):479–492. doi:10.1172/JCI64373.
   PubMed Web of Science ®Google Scholar
• Lin AS, Shuman JHB, Kotnala A, Shaw JA, Beckett AC, Harvey JL, Tuck M, Dixon B, Reyzer ML, Algood HMS. et al. Loss of corpus-specific lipids in Helicobacter pylori-induced atrophic gastritis. mSphere. 2021;6(6):e0082621. doi:10.1128/mSphere.00826-21.
   PubMed Web of Science ®Google Scholar
• Shuman JHB, Lin AS, Westland MD, Bryant KN, Piazuelo MB, Reyzer ML, Judd AM, McDonald WH, McClain MS, Schey KL. et al. Remodeling of the gastric environment in Helicobacter pylori-induced atrophic gastritis. mSystems. 2023;9(1):e0109823. doi:10.1128/msystems.01098-23.
   PubMed Web of Science ®Google Scholar
• Lin AS, McClain MS, Beckett AC, Caston RR, Harvey ML, Dixon B, Campbell AM, Shuman JHB, Sawhney N, Delgado AG. et al. Temporal control of the Helicobacter pylori Cag Type IV Secretion System in a Mongolian gerbil Model of gastric carcinogenesis. mBio. 2020;11(3). doi:10.1128/mBio.01296-20.
   Web of Science ®Google Scholar
• Hornsby MJ, Huff JL, Kays RJ, Canfield DR, Bevins CL, Solnick JV. Helicobacter pylori induces an antimicrobial response in rhesus macaques in a cag pathogenicity island-dependent manner. Gastroenterology. 2008;134(4):1049–57. doi:10.1053/j.gastro.2008.01.018.
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492.
   PubMed Web of Science ®Google Scholar
• Falush D, Wirth T, Linz B, Pritchard JK, Stephens M, Kidd M, Blaser MJ, Graham DY, Vacher S, Perez-Perez GI. et al. Traces of human migrations in Helicobacter pylori populations. Science. 2003;299(5612):1582–1585. doi:10.1126/science.1080857.
   PubMed Web of Science ®Google Scholar
• Bullock KK, Shaffer CL, Brooks AW, Secka O, Forsyth MH, McClain MS, Cover TL . Genetic signatures for Helicobacter pylori strains of West African origin. PloS ONE. 2017;12(11):e0188804. doi:10.1371/journal.pone.0188804.
   PubMed Web of Science ®Google Scholar
• Hatakeyama M. Anthropological and clinical implications for the structural diversity of the Helicobacter pylori CagA oncoprotein. Cancer Sci. 2011;102(1):36–43. doi:10.1111/j.1349-7006.2010.01743.x.
   PubMed Web of Science ®Google Scholar
• Higashi H, Tsutsumi R, Fujita A, Yamazaki S, Asaka M, Azuma T, Hatakeyama M. Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites. Proc Natl Acad Sci U S A. 2002;99(22):14428–14433. doi:10.1073/pnas.222375399.
   PubMed Web of Science ®Google Scholar
• Hayashi T, Senda M, Suzuki N, Nishikawa H, Ben C, Tang C, Nagase L, Inoue K, Senda T, Hatakeyama M. Differential mechanisms for SHP2 binding and activation are exploited by geographically distinct Helicobacter pylori CagA oncoproteins. Cell Rep. 2017;20(12):2876–2890. doi:10.1016/j.celrep.2017.08.080.
   PubMed Web of Science ®Google Scholar
• Suzuki M, Kiga K, Kersulyte D, Cok J, Hooper CC, Mimuro H, Sanada T, Suzuki S, Oyama M, Kozuka-Hata H. et al. Attenuated CagA oncoprotein in Helicobacter pylori from Amerindians in Peruvian Amazon. J Biol Chem. 2011;286(34):29964–72. doi:10.1074/jbc.M111.263715.
   PubMed Web of Science ®Google Scholar
• Touati E, Michel V, Thiberge JM, Wuscher N, Huerre M, Labigne A. Chronic Helicobacter pylori infections induce gastric mutations in mice. Gastroenterology. 2003;124(5):1408–1419. doi:10.1016/S0016-5085(03)00266-X.
   PubMed Web of Science ®Google Scholar
• Hatakeyama M. Helicobacter pylori CagA and gastric cancer: a paradigm for hit-and-run carcinogenesis. Cell Host Microbe. 2014;15(3):306–16. doi:10.1016/j.chom.2014.02.008.
   PubMed Web of Science ®Google Scholar
• Atherton JC, Tham KT, Peek RM Jr., Cover TL, Blaser MJ. Density of Helicobacter pylori infection in vivo as assessed by quantitative culture and histology. J Infect Dis. 1996;174(3):552–6. doi:10.1093/infdis/174.3.552.
   PubMed Web of Science ®Google Scholar
• Tan S, Noto JM, Romero-Gallo J, Peek RM Jr., Amieva MR. Helicobacter pylori perturbs iron trafficking in the epithelium to grow on the cell surface. PloS Pathog. 2011;7(5):e1002050. doi:10.1371/journal.ppat.1002050.
   PubMed Web of Science ®Google Scholar
• Skoog EC, Martin ME, Barrozo RM, Hansen LM, Cai LP, Lee SJ, Benoun JM, McSorley SJ, Solnick JV. Maintenance of type IV secretion function during Helicobacter pylori infection in mice. mBio. 2020;11(6). doi:10.1128/mBio.03147-20.
   PubMed Web of Science ®Google Scholar